Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report

Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report

Chromophobe renal cell carcinoma (ChRCC) is a rare pathological type of renal cell carcinoma (RCC). Related systematic studies involving large numbers of patients are lacking, and more importantly, there is currently no international consensus on post-line treatment guidelines for ChRCC. The rapid d...

Full description

Bibliographic Details
Main Authors:	Huimin Zhang, Xiaofeng Cong, Chen Chen, Ziling Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	chromophobe renal cell carcinoma sintilimab axitinib second-line treatment long survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1325999/full

Similar Items

Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma
by: Maximilian Erlmeier, et al.
Published: (2023-05-01)

Chromophobe: A rare histological variant of renal cell carcinoma
by: Adekunle AA, et al.
Published: (2023-09-01)

Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma
by: Moeinadin Safavi, et al.
Published: (2016-01-01)

Chromophobe Renal Cell Carcinoma.
by: Jyotsna Vijaykumar Wader, et al.
Published: (2013-04-01)

A rare case of synchronous association of chromophobe renal cell carcinoma with urothelial carcinoma of urinary bladder
by: A. Chaurasia, et al.
Published: (2017-06-01)

Imprint cytology of the chromophobe renal cell carcinoma: Correlation with the histological and ultrastructural features
by: Wonae Lee
Published: (2011-01-01)

CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma
by: Hui-feng Wu, et al.
Published: (2023-11-01)

Chromophobe renal cell carcinoma in an 18-year-old female
by: I. Saguem, et al.
Published: (2016-09-01)

Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
by: Chau V, et al.
Published: (2020-08-01)

Chromophobe renal cell carcinoma with clear cell features; a case report with review of literature
by: Anjum Ara, et al.
Published: (2021-07-01)

Smoking enhanced the expression of c-kit in chromophobe renal cell carcinoma
by: Jiahao Jiang, et al.
Published: (2023-10-01)

HISTOLOGICAL FEATURES OF CHROMOPHOBE RENAL CELL CARCINOMA
by: V. V. Baranovska, et al.
Published: (2020-03-01)

Compare fuhrman nuclear and chromophobe tumor grade on chromophobe RCC
by: Lin Tsu-Feng, et al.
Published: (2019-04-01)

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
by: Shuaishuai Li, et al.
Published: (2022-11-01)

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)
by: Marco Stellato, et al.
Published: (2023-01-01)

Concurrent angiomyolipoma and chromophobe renal-cell carcinoma in the same kidney: A case report
by: Guicao Yin, et al.
Published: (2023-05-01)

Chromophobe renal cell carcinoma: A report of two cases with unusual histological features
by: Marie Therese Manipadam, et al.
Published: (2008-01-01)

Abstract P-37: Ultrastructural Differential-Diagnostic Criteria for Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
by: Elena Smirnova, et al.
Published: (2019-06-01)

Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
by: Benjamin Lichtbroun, et al.
Published: (2023-07-01)

Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases
by: Shinji Tamada, et al.
Published: (2022-11-01)

Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
by: Yuki Katsumata, et al.
Published: (2021-10-01)

Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
by: Kazuyuki Numakura, et al.
Published: (2021-09-01)

Sarcomatoid chromophobe renal cell carcinoma: Cytohistopathological correlation of a case
by: Chakrabarti Indranil, et al.
Published: (2010-01-01)

Chromophobe Renal Cell Carcinoma and the Synchronous Presence of Primary Colon Malignancies. Is There a Relation?
by: Georgios Sahsamanis, et al.
Published: (2017-09-01)

Regorafenib combined with sintilimab as second-line treatment for advanced HCC patient: a case report
by: Yanzhi Wan, et al.
Published: (2023-10-01)

Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
by: Ruriko Honda‐Takinami, et al.
Published: (2020-03-01)

The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms
by: Hao Jiang, et al.
Published: (2023-05-01)

A case of hyperammonemia occurring during treatment of metastatic renal cell carcinoma with axitinib
by: Shoichi Kimura, et al.
Published: (2023-07-01)

Chromophobe renal cell carcinoma, oncocytic variant: Cytological and ultrastructural observations
by: Tadanori Yamaguchi, et al.
Published: (2015-01-01)

Axitinib in the treatment of renal cell carcinoma: patient selection and perspectives
by: Narayan V, et al.
Published: (2016-03-01)

Complete remission of brain metastases in renal cell carcinoma treated with axitinib after failure with nivolumab and ipilimumab treatment
by: Koichiro Takayama, et al.
Published: (2022-11-01)

Case report of a renal cell carcinoma patient with acute pancreatitis under both sunitinib and axitinib treatment
by: Utku Oflazoglu, et al.
Published: (2016-08-01)

Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review
by: Kenta Takahashi, et al.
Published: (2024-03-01)

Two Cases of Eosinophilic Variant Chromophobe Renal Cell Carcinoma, with a Rare Association of Right Atrial Myxoma in One of them
by: Sunil Kumar Yeshvanth, et al.
Published: (2011-07-01)

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study
by: Yoshihiko Tomita, et al.
Published: (2019-01-01)

Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
by: Masaki Murata, et al.
Published: (2019-04-01)

Avelumab plus axitinib therapy for renal cell carcinoma in a patient with pulmonary alveolar proteinosis: A case report
by: Nobuaki Shimizu, et al.
Published: (2021-11-01)

Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera
by: Renbo Guo, et al.
Published: (2017-09-01)

Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long‐term treatment‐free survival with pembrolizumab and axitinib in the KEYNOTE‐426 phase III trial of pembrolizumab and axitinib versus sunitinib
by: Koshiro Nishimoto, et al.
Published: (2022-05-01)

Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report
by: Ayano Uekawa, et al.
Published: (2022-11-01)